Suchergebnisse - "Myeloma"

PubPharm (9)

1

Differences and Similarities in Treatment Paradigms and Goals between AL Amyloidosis and Multiple Myeloma

in: Hemato | 2021

von Monique C. Minnema | Rimke Oostvogels | Reinier Raymakers | +1

2

A prospective, open-label, multicenter, observational study to evaluate the efficacy and safety of bortezomib-melphalan-prednisone as initial treatment for autologous stem cell transplantation-ineligible patients with multiple myeloma

enthalten in: Oncotarget | 2017

von Kim, M. | Kim, K. | Min, C. | +41

3

Galectins and disease implications for targeted therapeutics

Erschienen: Washington, DC, American Chemical Society, 2012

ACS symposium series - 1115

von Klesov, A. | Traber, P.

4

Twenty years of G-CSF : clinical and nonclinical discoveries

Erschienen: Basel, Springer, 2012

Milestones in drug therapy

von Molineux, G.

5

Twenty Years of G-CSF : Clinical and Nonclinical Discoveries

Erschienen: [s.l.], Springer-Verlag, 2012

Milestones in Drug Therapy

1. Aufl.

von Molineux, G. | Foote, M. | Arvedson, T.

6

The clinical effectiveness and cost-effectiveness of bortezomib and thalidomide in combination regimens with an alkylating agent and a corticosteroid for the first-line treatment of multiple myeloma : a systematic review and economic evaluation

Erschienen: Southampton, UK, NIHR Evaluation, Trials, and Studies Coordinating Centre, c2011

Health technology assessment - v. 15, no. 4

von Picot, J.

7

Bortezomib in the treatment of multiple myeloma

Erschienen: Basel, Springer, c2011

Milestones in drug therapy

von Ghobrial, I.

8

Towards individualized therapy for multiple myeloma : a guide for choosing treatment that best fits patients

Erschienen: Hackensack, NJ, World Scientific, c2009

von Teoh, G.

9

Report on the relative efficacy of oral cancer therapy for Medicare beneficiaries versus currently covered therapy : Part 4: Thalidomide for multiple myeloma

Erschienen: Rockville, Maryland, AHRQ Technology Assessment Program, [2005]

Technology assessment

von Abernethy, A. | McCrory, D.

1
[1]